# Traws Pharma, Inc. (TRAW)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TRAW/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -7.11M | $ -2.58M | $ 0 | $ -5.31M |
| 2025 | $ 2.80M | $ -8.56M | $ -8.95M | $ 0 | $ -629.0K |
| 2024 | $ 118.8K | $ -14.15M | $ -14.60M | $ 0 | $ -31.63M |
| 2023 | $ 244.4K | $ -20.49M | $ -9.64M | $ 0 | $ 10.67M |
| 2022 | $ 252.5K | $ -21.18M | $ -9.05M | $ 0 | $ 28.31M |
| 2021 | $ 268.6K | $ -19.21M | $ -10.19M | $ 0 | $ 46.12M |
| 2020 | $ 294.3K | $ -32.05M | $ -13.84M | $ 0 | $ 6.18M |
| 2019 | $ 2.82M | $ -27.76M | $ -13.25M | $ 0 | $ 11.57M |
| 2018 | $ 1.62M | $ -27.17M | $ -13.25M | $ 0 | $ 5.39M |
| 2017 | $ 1.06M | $ -32.46M | $ -22.12M | $ 0 | $ -11.69M |
| 2016 | $ 7.63M | $ -27.06M | $ -21.76M | $ 0 | $ 4.30M |
| 2015 | $ 16.08M | $ -33.67M | $ -43.86M | $ 0 | $ 10.01M |
| 2014 | $ 1.13M | $ -89.98M | $ -81.78M | $ 0 | $ 22.75M |
| 2013 | $ 6.76M | $ -88.95M | $ -88.17M | $ 0 | $ 80.41M |
| 2012 | $ 66.69M | $ -43.19M | $ 1.95M | $ 0 | $ -158.31M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | -2.54 |
| Current Ratio | 0.43 |

## Other views

- [Metrics](https://sponda.capital/en/TRAW.md)
- [Charts](https://sponda.capital/en/TRAW/charts.md)
- [Compare](https://sponda.capital/en/TRAW/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.